Months 46: The "Effective Dose" Window By month four, most patients reach what clinical trials call the "therapeutic dose." What happens: The medication has reached a steady state in your bloodstream
Notably, the Physical Activity Working Group of European Association for the Study of Obesity have recently highlighted that resistance training, rather aerobic exercise, attenuates lean body mass loss during weight-loss diets in adults with overweight or obesity ( Clinical studies using DEXA show that GLP-1based weight loss is accompanied by some loss of lean mass, but fat loss predominates
They help regulate appetite, stabilize blood sugar, and improve metabolic efficiencysupporting steady, natural weight loss
Hayami T, Kato Y, Kamiya H, et al
As little as one year off the drug was more than enough for study participants to lose benefits cultivated over years of continuous treatment
Please take a look at yet another study (L-Carnitine in the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis) ( this a case where the substance (LCar) itself is beneficial, but the by-products of its beakdown by gut flora are not